Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;53(11):2392-2403.
doi: 10.18502/ijph.v53i11.16941.

Preeclampsia: Etiology, Pathophysiology, Risk Factors, Impact and Prevention: A Narrative Review

Musliha Mustary  1 , Ansariadi  2 , Aminuddin Syam  3 , Shanti Riskiyani  4 , Kadek Ayu Erika  5 , Apik Indarty Moedjiono  6 , Mukhlis Lubis  7
Affiliations
Review

Preeclampsia: Etiology, Pathophysiology, Risk Factors, Impact and Prevention: A Narrative Review

Musliha Mustary et al. Iran J Public Health. 2024 Nov.

Abstract

Background: Preeclampsia (PE) caused 30%-40% of maternal and newborn deaths worldwide. Despite unclear exact cause, strategies exist to mitigate less severe PE effects. This review explores PE etiology, pathophysiology, risk factors, impact, and prevention.

Methods: Searching Scopus, PubMed, ProQuest, Google Scholar, and Science Direct for "preeclampsia and pregnancy" and "prevention" yielded 2012-2022 articles.

Results: Preeclampsia features abnormal placental changes, altered immunity response, trophoblast apoptosis, and reduced uterine perfusion. Risk factors include hypertension history, nulliparity, age over 40, BMI over 35 kg/m2, family history, amniotic pregnancy, and long pregnancy interval. This condition risks cardiovascular and neonatal morbidity, straining health resources. Prevention involves aspirin, vitamin D, exercise, folic acid, diet, early screening, and antenatal care.

Conclusion: Findings emphasize enhancing health literacy and preeclampsia education in prenatal care to mitigate PE risk among women. Further research, novel therapies, and assessing prevention strategies with accessible educational materials and multidisciplinary approaches are warranted to enhance pregnant women's health literacy and decrease PE risk.

Keywords: Etiology; Impact; Preeclampsia; Prevention; Risk factor.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:
Pathophysiology of Preeclampsia
See this image and copyright information in PMC

References

    1. Mukosha M, Vwalika B, Lubeya MK, et al. (2022). Determinants and neonatal outcomes of preeclampsia among women living with and without HIV at a tertiary hospital in Zambia: a review of medical records. Pan Afr Med J, 43: 110. - PMC - PubMed
    1. Mazloomi S, Khodadadi I, Alimohammadi S, et al. (2021). Correlation of thioredoxin reductase (TrxR) and nitric oxide synthase (NOS) activities with serum trace elements in preeclampsia. Clin Exp Hypertens, 43(2): 120–4. - PubMed
    1. Rezai H, Ahmad S, Alzahrani FA, et al. (2021). MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment. Redox Biol, 38: 101768. - PMC - PubMed
    1. Chappell LC, Brocklehurst P, Green ME, et al. (2019). Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet, 394 (10204): 1181–90. - PMC - PubMed
    1. Ortved D, Hawkins TLA, Johnson JA, et al. (2019). Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset preeclampsia. Ultrasound Obstet Gynecol, 53(2) : 239–44. - PubMed

LinkOut - more resources